SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Merck & Co., Inc. (Jobs) Receives Approvable Letter from FDA for EMEND(R) (fosaprepitant dimeglumine) For Injection; FDA Seeks More Data